1. Home
  2. DBVT vs TAYD Comparison

DBVT vs TAYD Comparison

Compare DBVT & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • TAYD
  • Stock Information
  • Founded
  • DBVT 2002
  • TAYD 1955
  • Country
  • DBVT France
  • TAYD United States
  • Employees
  • DBVT N/A
  • TAYD N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • TAYD Industrial Machinery/Components
  • Sector
  • DBVT Health Care
  • TAYD Industrials
  • Exchange
  • DBVT Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • DBVT 102.0M
  • TAYD 104.2M
  • IPO Year
  • DBVT N/A
  • TAYD N/A
  • Fundamental
  • Price
  • DBVT $4.40
  • TAYD $32.43
  • Analyst Decision
  • DBVT Strong Buy
  • TAYD
  • Analyst Count
  • DBVT 2
  • TAYD 0
  • Target Price
  • DBVT $22.50
  • TAYD N/A
  • AVG Volume (30 Days)
  • DBVT 28.3K
  • TAYD 20.0K
  • Earning Date
  • DBVT 03-06-2025
  • TAYD 03-27-2025
  • Dividend Yield
  • DBVT N/A
  • TAYD N/A
  • EPS Growth
  • DBVT N/A
  • TAYD 27.48
  • EPS
  • DBVT N/A
  • TAYD 2.70
  • Revenue
  • DBVT $12,515,000.00
  • TAYD $44,486,041.00
  • Revenue This Year
  • DBVT N/A
  • TAYD N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • TAYD N/A
  • P/E Ratio
  • DBVT N/A
  • TAYD $12.00
  • Revenue Growth
  • DBVT 125.54
  • TAYD 8.83
  • 52 Week Low
  • DBVT $0.44
  • TAYD $31.30
  • 52 Week High
  • DBVT $5.42
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 54.39
  • TAYD 41.80
  • Support Level
  • DBVT $4.18
  • TAYD $31.30
  • Resistance Level
  • DBVT $4.47
  • TAYD $32.50
  • Average True Range (ATR)
  • DBVT 0.28
  • TAYD 0.96
  • MACD
  • DBVT -0.04
  • TAYD 0.23
  • Stochastic Oscillator
  • DBVT 71.34
  • TAYD 48.29

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: